Foundation Medicine drops $150M follow-on; MicroLin ups range on IPO;

@FierceBiotech: AMRI plans to shutter an R&D shop to save cash. Story from FierceCRO | Follow @FierceBiotech

@JohnCFierce: Pfizer, AstraZeneca back a new strategy for cancer drug R&D. Article | Follow @JohnCFierce

@DamianFierce: FDA sends out obscure notice that it'll discuss a "Safety Communication on the use of a device for a certain medical procedure" at 1. | Follow @DamianFierce

@EmilyMFierce: Latest WHO update on Ebola outbreak in Western Africa: 224 cases, including 135 deaths. More | Follow @EmilyMFierce

> Foundation Medicine ($FMI) has dropped a $150 million follow-on offering, citing poor market conditions. Report

> The microRNA biotech MicroLin Bio has upped the price range on its proposed IPO to $10 to $12. The company now plans to raise about $30 million from the sale of 2.7 million shares. Story

Medical Device News

@FierceMedDev: ForSight Vision5 ropes in $15M in Series C financing to develop its intraocular therapy. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: Abbott's device sales slip as diagnostics keeps revenue rolling. Story | Follow @VarunSaxena2

@EmilyWFierce: ICYMI yesterday: Boston Scientific scores FDA approval for a new crop of implantable cardiac devices. More | Follow @EmilyWFierce

@MichaelGFierce:  MIT team delivers three ovarian cancer drugs with one particle. Story from FierceDrugDelivery | Follow @MichaelGFierce

> Convergent Dental pockets $8M for 'dread-free' laser. Story

> Foundation Medicine ditches plans to raise $150M. Item

> Endo's AMS hit with an FDA warning letter. News

> Report: Surgical device maker Conmed shopping itself around. More

Pharma News

@FiercePharma: Tops on FP yesterday: Novartis marks 235 admin jobs for deletion amid companywide restructuring. Story | Follow @FiercePharma

@TracyStaton: ICYMI: Juicy trade-secrets dispute between Bristol-Myers + its ad agency and an account manager who jumped ship. Report | Follow @TracyStaton

@EricPFierce: FDA says import alert for saline made at Baxter plant in Canada has no connection to shortage in U.S. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: Our newest special report is live! Top 10 M&A deals of 2013. Feature | Follow @CarlyHFierce

> GlaxoSmithKline steps up bribery probes, eyeing potential violations in 9 Middle Eastern countries. Report

> Under fire from local pharmas, China backs off price caps. More

> Gilead's Sovaldi, GSK's Anoro stand out in 2014's blockbuster crop, report says. Article

Pharma Manufacturing News

> Novartis' Sandoz unit recalls some Ritalin over packaging issue. Article

> Bill for California statewide disposal law lands in the trash. Story

> Counterfeits of Roche's Herceptin found in EU supply chain. More

> Novartis' Alcon opens $160M plant in Singapore. News

> U.K. starts work on $64M biologics manufacturing center. Report

Vaccines News

> Ebola deaths rise to 135 as vaccine research lags. Report

> Merck, Sanofi hope for sales expansion with two-dose Gardasil switch. Story

> Whooping cough mutations may be weakening vaccine effectiveness. More

> New Novartis director will implement Bexsero on U.K. immunization program. Item

> Dynavax initiates PhIII study it hopes will quell FDA's safety concerns. Article